Greenberg Traurig has represented Japan’s Ono Pharmaceutical Co on its $2.4 billion acquisition of  U.S.-based cancer drugmaker Deciphera, which was advised by Goodwin Procter.

According to Reuters, the deal will help Ono expand its oncology portfolio and presence in the United States and Europe.

Deciphera's oral drug Qinlock, which treats a type of gastrointestinal cancer, received the U.S. Food and Drug Administration's full approval in 2020. The company also plans to seek a nod for vimseltinib, its experimental medicine to treat tenosynovial giant cell tumour, a type of tumour found in some joints, Reuters added.

The Greenberg Traurig team was co-led by shareholders Chia-Feng Lu and Michael D. Helsel, while the Goodwin team was helmed by global M&A head Stuart Cable and partners Richard Hoffman, Lisa Haddad, and James Ding.



Related Articles

STB, AMT and TMI assist on $1.7 bln Blackstone Japan deal

by Nimitt Dixit |

U.S. law firm Simpson Thacher & Bartlett and Japan’s firm Anderson Mori & Tomotsune are advising global investment giant Blackstone on its $1.74 billion (275.8 billion yen) bid to take private Japanese digital comic distributor Infocom, which has hired TMI Associates to represent it.

PAG GC to join MoFo Tokyo as partner

Morrison & Foerster is set to boost its private equity and M&A practices in Asia with the hire of veteran corporate lawyer Gregory Salathé as a partner in Tokyo. Salathé will join the firm in September from investment manager PAG, where he is currently a partner and group general counsel.

A&G, WongP acting on OCBC’s $1 bln buyout offer for Great Eastern

Singapore Big Four law firm WongPartnership is advising insurer Great Eastern Holdings in relation to a S$1.4 billion ($1 billion) buyout offer from its top shareholder, Oversea-Chinese Banking Corporation (OCBC), which is being represented by Allen & Gledhill.